Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)
Inogen (INGN) posted quarterly Non-Current Deferred Tax Liability of $6.6 million for Q1 2026, down 11.3% year-over-year from $7.4 million in Q1 2025, and down 2.62% quarter-over-quarter from $6.7 million in Q4 2025.
Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends
Inogen (INGN) has reported Non-Current Deferred Tax Liability for 10 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 11.3% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $6.6 million (down 11.3% YoY), while the FY2025 annual figure was $6.7 million, down 2.86% from the prior year.
- Non-Current Deferred Tax Liability eased to $6.6 million in Q1 2026 per INGN's latest filing, from $6.7 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $8.8 million in Q4 2023 and bottomed at $6.6 million in Q1 2026.
- Historically, Non-Current Deferred Tax Liability has averaged $7.8 million across 5 years, with a median of $8.0 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability increased 1.52% — and 2024, when it decreased 21.1%.
- Inogen's Non-Current Deferred Tax Liability stood at $8.7 million in 2022, then advanced by 1.52% to $8.8 million in 2023, then dropped by 21.1% to $6.9 million in 2024, then declined by 2.86% to $6.7 million in 2025, then declined by 2.62% to $6.6 million in 2026.
- Business Quant data shows INGN's Non-Current Deferred Tax Liability at $6.6 million in Q1 2026, $6.7 million in Q4 2025, and $7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Inogen | 151.59 Mn | 46.05 Mn | 43.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.49 Mn |
| Jun 30, 2026 | 6.49 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Mar 31, 2026 | 6.57 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Sep 30, 2025 | 7.89 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Jun 30, 2025 | 7.95 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Mar 31, 2025 | 7.41 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Dec 31, 2024 | 6.95 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Sep 30, 2024 | 8.38 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Jun 30, 2024 | 8.07 Mn |
| Mar 31, 2024 | 8.15 Mn |
| Mar 31, 2024 | 8.15 Mn |